Key Takeaways
- Tariff fog masks underlying resilience: Sequential revenue moderated as export customers deferred orders on US tariff uncertainty, yet gross margin improved 81 bps YoY and Barium chemicals won a full tariff exemption.
- Strontium launch is a near-term catalyst: Trial runs are underway, commercial sales begin in September, and a competitor's fire has removed 24,000 tons of supply, opening a gap Vishnu is timed to fill.
- Backward integration is the margin engine: Ramadas Minerals already supports ~30% Barium EBITDA, Chrome ore integration arrives early next year, and a third undisclosed project is in R&D.
- The export playbook is pivoting to domestic: Management now targets a 60:40 domestic-export mix, trading slightly lower realizations for faster collections and insulation from tariff fluidity.
- What to watch next quarter: Whether pent-up demand materializes as tariff clarity emerges, the Strontium commercial ramp, and the mine acquisition closing by November 2025.
Tariff Disruption & Demand Deferment
- Sequential hit concentrated in exports: Customers across export markets took a cautious inventory stance as US tariff rates swung from 10% to a threatened 25-50%, directly suppressing order flow and order book.
- Barium shielded by exemption: Barium chemicals were placed on Annexure 2 and are totally exempted from US tariffs, insulating a core vertical from the disruption hitting Chromium.
- Chromium exposure is fluid and small: US Chromium shipments currently face a 10% duty borne by the customer, but management declined to comment on viability if rates reach 145%. Q1 US exports across Chrome and Barium were estimated at only $2-3 million.
- Second-order effects compound the fog: Tariff uncertainty creates ripple effects through other countries that eventually sell to America, producing an environment of diffidence that makes top-line guidance academic.
- Pent-up demand is the recovery bet: Management argues its chemical portfolio cannot be substituted, so deferred volumes should flow through the rest of the year once tariff clarity returns.
Siddartha Cherukuri: "Though it is hard to predict, we are hopeful that pent-up demand will flow through the rest of the year as our portfolio of chemicals cannot be substituted."
Strontium: The Next Growth Vector
- India's sole producer, launching into a supply gap: Vishnu will be the only manufacturer of Strontium carbonate in India, and a fire at a Mexican facility has removed ~24,000 tons of product from the global market.
- Commercial timeline is imminent: Trial runs are ongoing as of August, with first commercial sales expected in September and consistent volumes from October. Production formally starts in Q3.
- Strategic positioning: Strontium carbonate is a cost-effective alternative to rare earths, providing strong magnetic properties for flexible and permanent magnets in high demand.
Siddartha Cherukuri: "And in Mexico, one of the facilities which was manufacturing Strontium carbonate had a fire accident. So, close to 24,000 tons of product is out of the market. So, there is definitely a gap which we can fill. So, the launch is going to happen at the right time."
Margin Structure & Cost Levers
- Gross margin improved despite revenue headwinds: Gross margin rose 81 bps YoY to ~46%, while manufacturing expense as a percentage of revenue declined 100 bps YoY to 6.2% on ongoing process improvements.
- Freight costs spiked then eased: Ocean freight rates surged between May and early June on tariff-related developments and peak season surcharges, pushing shipping and forwarding costs up 88 bps sequentially. Rates began easing from mid-June.
- Barium EBITDA anchored at ~30%: The Ramadas Minerals backward integration benefit is fully factored in, and management expects the combined Barium subsidiary and Ramadas margin to continue, perhaps even improve.
- Chromium margin jump is structural: A 500 bps sequential gross margin improvement came partly from softening Chrome ore prices and partly from better operating levels yielding economies of scale. Chrome ore backward integration arriving early next year will further improve the cost position.
- Export vs. domestic margin trade-off: Export realizations are 1-1.5% better than domestic, but domestic offers superior collections with payment terms of one month or less, sometimes cash-and-carry, versus export receivables extending beyond 45 days.
Strategic Pivot: Domestic Focus & Product Mix
- Mix shifting to 60:40 domestic-export: Management will focus more on the domestic market going forward, citing resilient Indian demand and consumer sentiment even as tariff effects ripple globally.
- Chromium moving beyond leather: The company is deliberately shifting toward metal plating, wood preservative, pigments and dyes, and Chromium metal. Leather exposure is declining year-on-year, though long-term relationships in that segment will be maintained.
- Derivatives provide flexibility, not margin uplift: Management clarified that derivatives do not inherently add more margin; they provide the flexibility to deliver product where demand exists.
- Volume growth confidence intact: Despite tariff uncertainty, management is confident of delivering 10% volume growth due to substantial plant improvements yielding better output at lower raw material consumption. Capacity utilization on both Chromium and Barium sides continues to surpass last year's 80%+ levels.
Siddartha Cherukuri: "It could be focusing on metal plating, wood preservative, and pigments and dyes, as well as Chromium metal. That is what we are going to focus on. It doesn't mean that we are going to do away with the leather business because that is something, we have those long-term relationships."
Balance Sheet, CAPEX & Mine Acquisition
- Mine acquisition awaiting statutory approvals: The application is pending with the government for regulatory clearances; management anticipates completion in Q3 FY26, probably on or before November 2025. No new developments were reported this quarter.
- CAPEX priorities are execution-first: The immediate focus is completing existing projects, including the Strontium chemistry foray. Future investment strategy in Chromium and Barium verticals will be formulated once tariff stabilization brings clarity.
- Debt trajectory tied to CAPEX plan: Management declined to provide debt guidance, stating it is subject to the CAPEX plan and that more clarity will emerge once the tariff issue subsides and markets stabilize.
- Cash position in line with March 2025: Management declined to disclose the current cash figure since the balance sheet was not shared, stating only that it is in line with the reported Rs. 81.7 crores as of 31 March 2025.
- R&D is fully expensed, outsourced: All R&D expenditure is outsourced to a third party and expensed monthly under current P&L heads, which is why no separate R&D line item appears. There is no capitalization.
Hanumant Bhansali: "The application is pending with the government for regulatory approvals and clearances. The acquisition will be completed as soon as we get the government approval. And it is only a matter of time. We are anticipating it could happen anywhere in the third quarter of the financial year, probably on or before November 2025."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Volume growth | Confident of delivering 10% growth in volumes despite tariff uncertainty | FY26 |
| Strontium commercial launch | Commercial sales begin September, consistent volumes from October | Q2-Q3 FY26 |
| Mine acquisition closure | Anticipated on or before November 2025, pending government approvals | Q3 FY26 |
| Chrome ore backward integration | Expected to improve cost position | Early next year (CY2026 / early FY27) |
| Domestic-export mix shift | Moving toward 60:40 domestic-export share | Moving forward (undated) |
| Barium EBITDA | Maintain close to 30%, perhaps improve | Ongoing |
Key Metrics
| Metric | Q1 FY26 |
|---|---|
| Consolidated operating revenue | ₹346.9 cr, +2.4% YoY vs ₹338.9 cr in Q1 FY25 |
| Consolidated gross margin | 45.6%, +81 bps YoY vs 44.8% in Q1 FY25 |
| Consolidated EBITDA | ₹55.7 cr, +0.2% YoY |
| Consolidated EBITDA margin | 16.1%, vs 16.4% in Q1 FY25 |
| Consolidated PAT | ₹32.2 cr, +5.8% YoY vs ₹30.5 cr in Q1 FY25 |
| Consolidated PAT margin | 9.3%, vs 9% in Q1 FY25 |
| Standalone gross margin improvement | 470 bps sequential improvement |
| Standalone EBITDA margin improvement | 185 bps sequential improvement |
| Consolidated domestic:export sales mix | 55:45 |
| Consolidated manufacturing expense as % of revenue | 6.2%, declined 100 bps YoY |
| Shipping and forwarding costs | +88 bps sequential increase |
| Consolidated sales exposure to USA | 7% of total consolidated sales; Chromium 5%, Barium 12% |
| Net debt | ₹250 cr as of 30th June 2025; net debt to equity ~0.25x |
| CAPEX spent on Vishnu Strontium Private Limited | ₹46 cr till 30th June 2025 |
| Barium subsidiary EBITDA margin | Close to 30%; 29.1% in previous quarter |
| Chromium chemicals capacity utilization | In excess of 80% last year, continuing to surpass this year |
| R&D expenditure as % of consolidated sales | ~0.5% |
| Sodium dichromate capacity | 80,000 tons; 30-33% sold as SDC, 67% converted to derivatives |
| Chromium derivatives revenue contribution | ~70% of Chromium business |
| Strontium carbonate plant capacity | 12,000 tons per annum |
| Chromium chemicals global demand CAGR | 4.5% to 5.5% |
| Barium chemicals global demand CAGR | 5.5% to 6.5% |